Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2007
03/13/2007US7189722 Aryl spirohydantoin CGRP receptor antagonists
03/13/2007US7189720 Selective NPY (Y5) antagonists
03/13/2007US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses
03/13/2007US7189714 Administering quinoline derivative as analgesic
03/13/2007US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis
03/13/2007US7189268 Using an 2-azoimidazole compound; dyeing human hair
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/13/2007CA2315227C Arylpiperazines having activity at the serotonin 1a receptor
03/13/2007CA2274592C Pyrazole derivatives
03/13/2007CA2267224C Vitronectin receptor antagonists
03/13/2007CA2138452C Substituted 1-arylpyrazoles
03/08/2007WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
03/08/2007WO2007028118A2 Nicotinic acid and picolinic acid derived near-infrared fluorophores
03/08/2007WO2007028083A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007WO2007027950A1 Substituted benzimidazoles and methods of preparation
03/08/2007WO2007027842A1 Anilinopyrazole derivatives useful for the treatment of diabetes
03/08/2007WO2007027729A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007WO2007027594A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007WO2007027528A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
03/08/2007WO2007026962A1 Phenylene derivative
03/08/2007WO2007026916A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
03/08/2007WO2007026847A1 Compound having triazole ring structure substituted with pyridyl group and organic electroluminescent device
03/08/2007WO2007026664A1 Sulfonamide compound
03/08/2007WO2007026215A1 Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
03/08/2007WO2007026188A1 Process for the manufacture of antiulceratives
03/08/2007WO2007026097A1 Novel indole compounds
03/08/2007WO2007025901A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/08/2007WO2007025900A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators
03/08/2007WO2007025709A2 Organic compounds
03/08/2007WO2007025604A1 4-chromenonyl-1,4-dihydropyridines and their use
03/08/2007WO2007025575A1 O-hydroxy- and o-amino benzamide derivatives as ikk2 inhibitors
03/08/2007WO2007009686A3 Substituted pyrazoline compounds, their preparation and use as medicaments
03/08/2007WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
03/08/2007WO2007003962A3 Gpcr agonists
03/08/2007WO2006128635A3 Method for producing n,n-bis(pyridin-2-yl-methyl)-1,1-bis(pyridin-2-yl)-1-aminoalkane compounds and metal complex salts containing these compounds
03/08/2007WO2005086844A3 Magnetism to control friction checks for rods
03/08/2007WO2004026846A8 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
03/08/2007US20070055459 Structure-based approach to design of protein-processivity factor interactions
03/08/2007US20070055081 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones
03/08/2007US20070054945 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form
03/08/2007US20070054942 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases
03/08/2007US20070054933 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/08/2007US20070054928 c-Met modulators and methods of use
03/08/2007US20070054924 Novel piperidines as chemokine modulators (ccr)
03/08/2007US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054921 Substituted indoles and a process for preparing substituted indoles
03/08/2007US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
03/08/2007US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
03/08/2007US20070054909 VLA-4 inhibitor compounds
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054892 Isoquinoline potassium channel inhibitors
03/08/2007US20070054881 Anxiolytic agents with reduced sedative and ataxic effects
03/08/2007US20070051919 Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and lcd device including the liquid crystal composition
03/08/2007CA2822094A1 Isoindole-imide compounds and compositions comprising and methods of using the same
03/08/2007CA2621182A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
03/08/2007CA2620818A1 Amide derivatives as rock inhibitors
03/08/2007CA2620658A1 Novel indole compounds
03/08/2007CA2620631A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
03/08/2007CA2620425A1 Anilinopyrazole derivatives useful for the treatment of diabetes
03/08/2007CA2620352A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007CA2620269A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007CA2620222A1 Organic compounds
03/08/2007CA2620129A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/08/2007CA2620085A1 Isoindole-imide compounds and compositions comprising and methods of using the same
03/08/2007CA2619966A1 Substituted benzimidazoles and methods of preparation
03/08/2007CA2619898A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/08/2007CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007CA2616797A1 Benzodiazepine derivatives , their preparation and the therapeutic use thereof
03/08/2007CA2615866A1 4-chromenonyl-1,4-dihydropyridines and their use
03/07/2007EP1760079A1 Compounds as cor5 antagonists
03/07/2007EP1760076A1 FAP Inhibitors
03/07/2007EP1758895A1 Gonadotropin releasing hormone receptor antagonists
03/07/2007EP1758892A1 Compounds and compositions as protein kinase inhibitors
03/07/2007EP1758891A2 Benzimidazolone carboxylic acid derivatives
03/07/2007EP1758890A1 7-pyrazolylbenzazepines having affinity for d3 receptor
03/07/2007EP1758889A1 Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
03/07/2007EP1758888A1 Butyrylcholinesterase selective inhibitors
03/07/2007EP1758887A1 Pyrimidine derivatives for the treatment of abnormal cell growth
03/07/2007EP1758886A1 Piperazinediones as oxytocin receptor antagonists
03/07/2007EP1758885A1 Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
03/07/2007EP1758882A1 Amido compounds and their use as pharmaceuticals
03/07/2007EP1758869A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
03/07/2007EP1758868A1 Novel cis-imidazolines
03/07/2007EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
03/07/2007EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists
03/07/2007EP1758859A1 Glucagon receptor antagonists, preparation and therapeutic uses
03/07/2007EP1758857A1 Indole derivatives as antiviral agents
03/07/2007EP1758856A2 Indole derivatives for the treatment of obesity
03/07/2007EP1758847A1 Inhibitors of histone deacetylase
03/07/2007EP1758580A2 N-substituted piperidines and their use as pharmaceuticals
03/07/2007EP1758578A2 Novel indazole carboxamides and their use
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 1080